Vairavan Latha bought ARQT
February 27, 2026 · Form 4 insider transaction
Vairavan Latha bought 27,000 shares of Arcutis Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
27,000
Price
$0.00
Total value
N/A
InsiderVairavan Latha
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after90,607
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Constitute Restricted Stock Units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting, in which 25% of the RSUs vest annually on March 1, (the "Vesting Commencement Date"), of each year beginning March 1, 2027, subject to the Reporting Person's continued service to the Issuer.